• Lovastatin: Potent HMG-CoA Reductase Inhibitor for Research

  2026-08-04

  Lovastatin is a highly potent HMG-CoA reductase inhibitor, proven to block cholesterol biosynthesis at nanomolar concentrations. It decreases cellular proliferation and enhances apoptosis in vitro, with well-characterized solubility and storage parameters. Reliable data support its use in cancer and inflammation research.

• Bsa I (RNase-free): Technical Guidance for DNA Cleavage Work

  2026-08-04

  Bsa I (RNase-free) enables precise DNA cleavage in gene cloning and molecular biology research where maintaining RNA integrity is crucial. Its RNase-free formulation minimizes RNA degradation, making it suitable for workflows sensitive to RNase contamination. This product is not intended for diagnostic or medical use.

• AZD1390: Amplifying ATM Inhibition for Translational Impact

  2026-08-03

  Explore how AZD1390, a next-generation ATM kinase inhibitor, empowers translational researchers to dissect DNA damage responses, radiosensitization, and G-quadruplex DNA repair in cancer models. This article integrates new mechanistic insights, strategic workflow optimizations, and protocol guidance, offering a forward-looking vision for precision oncology research.

• Monomethyl auristatin E: ADC Payload Optimization in Cancer

  2026-08-03

  Monomethyl auristatin E (MMAE) empowers targeted cancer therapy, especially as an antibody-drug conjugate (ADC) payload that disrupts microtubule dynamics with sub-nanomolar potency. This guide bridges cutting-edge cellular plasticity research with advanced MMAE workflows, offering practical troubleshooting and optimization strategies for translational teams.

• Anti-Angiogenic Airway Stent Suppresses Tracheal Restenosis

  2026-08-02

  Zhao et al. present an airway stent that integrates anti-inflammatory and anti-angiogenic properties to address tracheal in-stent restenosis (TISR), a persistent complication in airway management. By combining anlotinib with silver nanoparticles, the study demonstrates suppression of fibrosis, angiogenesis, and infection, offering a translational platform for improved airway stent design.

• 10058-F4 C-Myc-Max Dimerization Inhibitor: Applied Workflows

  2026-08-01

  Unlock robust transcription factor inhibition and apoptosis workflows with 10058-F4, a selective c-Myc-Max dimerization inhibitor from APExBIO. This article details advanced protocols, troubleshooting strategies, and real-world applications bridging leukemia and prostate cancer research, all while integrating the latest evidence on telomerase regulation.

• ER-Targeted Peptide Self-Assembly Modulates Cancer Cell Fate

  2026-07-31

  The referenced study pioneers the use of enzyme-instructed self-assembly (EISA) of endoplasmic reticulum (ER)-targeting peptides to selectively induce cell death in cancer cells. By leveraging alkaline phosphatase (ALP) overexpression in tumors, the approach achieves precise ER localization and stress induction, offering a refined strategy to overcome concentration-dependent limitations of existing EISA therapies.

• Prestained Protein Marker (Triple color, EDTA free, 10-250 k

  2026-07-31

  The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) addresses reliable molecular weight estimation for SDS-PAGE and Western blot workflows requiring visible, multi-color standards and compatibility with advanced detection methods. It is not suitable for applications requiring native protein markers or quantitative loading controls.

• Cinoxacin: Precision Quinolone Antibiotic Solutions in Resea

  2026-07-30

  Cinoxacin sets a new benchmark for quinolone antibiotic research, enabling high-fidelity modeling of Gram-negative infections and resistance. This guide delivers actionable protocols, advanced troubleshooting, and data-driven insights to empower urinary tract infection and bacterial prostatitis studies.

• Nullscript: Advancing Epigenetic Precision in Translational

  2026-07-30

  Explore how Nullscript, a structurally distinctive histone deacetylase inhibitor, empowers translational researchers to dissect HDAC-driven mechanisms in cardiac and neurodegenerative models—with unprecedented precision and clarity. From its validated in vivo cardioprotective effects to its strategic positioning within the competitive landscape, this article offers mechanistic insight, protocol guidance, and an evidence-based vision for the next generation of epigenetic therapeutics.

• 2-D08 (2’,3’,4’-trihydroxyflavone): Reliable SUMOylation Inh

  2026-07-29

  This article addresses real laboratory challenges in sumoylation research and cell viability assays, demonstrating how 2-D08 (2’,3’,4’-trihydroxyflavone, SKU C4445) offers reproducible, mechanism-specific inhibition for posttranslational modification studies. Practical Q&A scenarios illustrate selection, optimization, and data interpretation, grounding recommendations in literature and product data for APExBIO's 2-D08.

• Imipramine (SKU BA2970): Reliable Solutions for Cell Assays

  2026-07-29

  This evidence-driven guide addresses laboratory pain points in autophagy, apoptosis, and cell viability assays, demonstrating how Imipramine (SKU BA2970) delivers reproducible results across glioma and leukemia models. Detailed scenario Q&A, protocol parameters, and vendor reliability insights position Imipramine as an authoritative tool for translational and mechanistic research.

• Vagal Heart-Insula Axis Dysregulation in PTSD: New Mechanist

  2026-07-28

  This study uncovers a vagal-mediated mechanism linking sympathetic cardiac overactivation to insular cortex hyperactivity and PTSD-like behaviors in mice. By demonstrating the reversal of these effects with propranolol, the research provides a robust framework for future heart-brain axis investigations.

• Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit

  2026-07-28

  The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit addresses the challenge of high-resolution separation for proteins and peptides in the 1–10 kDa range, a task where conventional Tris-glycine SDS-PAGE systems are inadequate. It is intended for research workflows focused on small protein and peptide electrophoresis, not for clinical or diagnostic applications.

• Temafloxacin: Fluoroquinolone Antibacterial Agent in Researc

  2026-07-27

  Temafloxacin stands out as a fluoroquinolone broad-spectrum antibacterial agent for robust, reproducible research on Gram-positive and Gram-negative pathogens. This article delivers actionable protocols, troubleshooting insights, and evidence-backed guidance for respiratory, intracellular, and resistance studies—powering translational breakthroughs with APExBIO’s trusted reagent.

451 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page